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Introduction
over recent decades, small animal transfusion medicine has made 
significant progress, contributing to the development of emergency
medicine and critical care. The availability of blood components has
increased the number of indications for transfusing cats and dogs,
even if the evidence-based benefit is still lacking in certain cases.1
Fresh whole blood is readily available to clinicians because it can 
be taken from in-house donor cats or ‘volunteer’ feline blood donors.
Thanks to the commercial availability of in-house typing kits and gel
cross-match systems for cats, blood transfusion in veterinary practice
has become safer and more accessible.2 However, blood transfusion
implies a certain amount of risk to the recipient cat and, to some extent,
the donor cat as well, which is subjected to an invasive procedure
requiring sedation.3 These risks always need to be carefully weighed
against the achievable benefits. in terminal patients, blood transfusion
should be avoided and other treatment options considered.4
Surprisingly, blood transfusion did not reduce the risk of 30-day 
mortality in humans in a critical care setting in one multi-centre, 
randomised controlled study.5
immediate or delayed adverse reactions can occur during or after
transfusion, related to immune-mediated mechanisms. The severity of
these reactions varies from a mild febrile reaction to a severe, life-
threatening circulatory overload or haemolytic crisis. The prevention
of this risk is not the objective of these guidelines, and guidance is 
provided elsewhere.1,2,4,6–10
This guideline article focuses on the prevention of transmission of
infectious disease related to blood transfusion in cats. Adverse events
caused by infectious agents may originate from: contamination of
blood following incorrect collection, storage or transfusion; or transfu-
sion of contaminated blood obtained from an infected donor.
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Overview: The availability of blood components has
increased the number of indications for transfusing
cats, and fresh whole blood is readily accessible to
clinicians because it can be taken from in-house
donor cats or ‘volunteer’ feline blood donors. A
certain amount of risk remains to the recipient cat, 
as immediate or delayed adverse reactions can occur
during or after transfusion, related to immune-
mediated mechanisms. This article, however, focuses
on adverse events caused by infectious agents,
which may originate either from contamination of
blood following incorrect collection, storage or
transfusion, or from transfusion of contaminated
blood obtained from an infected donor.
Prevention of blood contamination: In cats,
blood cannot be collected through a closed system
and, therefore, collection of donor blood requires 
a multi-step manipulation of syringes and other
devices. It is crucial that each step of the procedure
is performed under the strictest aseptic conditions
and that bacterial contamination of blood bags is
prevented, as bacterial endotoxins can cause an
immediate febrile reaction or even fatal shock in the
recipient cat.
Prevention of disease transmission: With a 
view to preventing transmission of blood-borne
infectious diseases, the American College of
Veterinary Internal Medicine has adopted basic
criteria for selecting pathogens to be tested for in
donor pets. The worldwide core screening panel 
for donor cats includes feline leukaemia virus, feline
immunodeficiency virus, Bartonella species and
feline haemoplasma. The list should be adapted to
the local epidemiological situation concerning other
vector-borne feline infections. The most practical,
rapid and inexpensive measure to reduce
transfusion risk is to check the risk profile of 
donor cats on the basis of a written questionnaire.
Blood transfusion can never, however, be
considered entirely safe.
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ABCD guidelines for minimising risks 
of infectious iatrogenic complications
588 JFMS CLINICAL PRACTICE




Corresponding author: Maria Grazia Pennisi
Email: mariagrazia.pennisi@unime.it
doi: 10.1177/1098612X15588449
© Published by SAGE on behalf of iSFM and AAFP 2015
Maria Grazia Pennisi, Katrin Hartmann, Diane D Addie, Hans Lutz, 
Tim Gruffydd-Jones, Corine Boucraut-Baralon, Herman Egberink, 
Tadeusz Frymus, Marian C Horzinek, Margaret J Hosie, Albert Lloret, 
Fulvio Marsilio, Alan D Radford, Etienne Thiry, Uwe Truyen and Karin Möstl
588_593_Blood transfusion.qxp_FAB  27/05/2015  15:28  Page 588
 at Universite de Liege on November 8, 2015jfm.sagepub.comDownloaded from 
JFMS CLINICAL PRACTICE 589
Prevention of contamination 
of donor blood
The blood collection procedure in cats is associ-
ated with a greater risk of contamination than in
dogs or humans. in cats, blood cannot be collect-
ed through a closed system, and therefore a
multi-step manipulation of syringes and other
devices is required, with the help of several
assistants. This increases the risk of contamina-
tion. in general, 50 ml of blood is collected from
donor cats using three (20 ml) or five (10 ml) dif-
ferent syringes, each containing the appropriate
quantity of anticoagulant obtained from a
human blood collection bag.4 Usually, a T-con-
nector and a three-way tap connect the intra-
venous (iV) needle to the syringes, which are
filled with blood and then gently rotated by an
assistant. The blood collected into the syringes is
then immediately transferred into a single, plain
blood collection bag through the injection port
(Figure 1). Finally, blood is transfused through a
giving set which is inserted into another port of
the bag at the time of the transfusion procedure.
it is crucial that each step of the process is
performed under the strictest aseptic condi-
tions, even in an emergency.11 The disposable
equipment should be placed on sterile sur-
faces, and staff should wear sterile gloves and
masks. Each syringe should be immediately
sealed with its capped needle, both after
adding the anticoagulant and after collecting
the blood until it is transferred into the bag.
Surgical preparation of the ventral neck of the
donor is necessary. The longer the delay
between blood collection and transfusion, the
higher the risk of contamination of the collect-
ed blood. Collected blood should be stored at
4°C. However, the blood bag should not be
stored once the giving set has been inserted.
Similar principles apply in the case of
autolo gous transfusion, a procedure reported
in dogs in emergency situations such as for
treatment of haemothorax or haemoperi-
toneum. Here, blood is collected from the
body cavity using cell salvage devices and
transfused after appropriate washing.10,12
Bacterial contamination of blood bags can
cause an immediate febrile reaction in the
recipient if bacterial endotoxins are produced
by cold-growing gram-negative bacteria, such
as Pseudomonas species, or coliforms, such as
Serratia marcescens. The latter microorganism
has been isolated from contaminated feline
blood bags and from transfused cats that pre-
sented with fever, vomiting, diarrhoea, jaun-
dice and even death.13 Fatal endotoxin-related
shock is the most dangerous consequence in
such cases.
Blood bags should be visually inspected before
use and discarded if there is any suspected
change in colour or other visible abnormality.14
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European Advisory
Board on Cat Diseases
The European Advisory
Board on Cat Diseases
(ABCD) is a body of
experts in immunology,
vaccinology and clinical
feline medicine that issues
guidelines on prevention
and management of feline
infectious diseases in
Europe, for the benefit of
the health and welfare 
of cats. The guidelines 
are based on current
scientific knowledge of
the diseases and available
vaccines concerned. 
The latest version of 
the guidance provided




Figure 1 Transfer of blood
collected with syringes into
a single, plain blood
collection bag through the
injection port. Courtesy of
Eva Spada, University of Milan,
Milan, Italy
Testing is recommended for pathogens that meet at least three 
of the following criteria:
< Documented clinical disease produced in recipients by blood
transmission
< Possibility of subclinical infections (healthy carrier state)
< Possibility of cultivation from the blood of an infected animal
< The disease caused is severe or difficult to clear
Testing is conditionally recommended when:
< Only experimental transmission by blood is documented
< The disease caused is not severe in most cases or is easily overcome
When  a nd  wha t  t o  s c re en  fo r
Prevention of transmission of
blood-borne infectious diseases
information on feline blood-borne infectious
agents is becoming increasingly available, in
particular in relation to vector-borne patho -
gens.15,16 in 2005, in a consensus statement on
canine and feline blood donor screening for
infectious diseases, the American College of
Veterinary internal Medicine (ACViM) adopt-
ed basic criteria for selecting pathogens to be
tested for in donor pets.14 Testing is recom-
mended for pathogens in certain circum-
stances, as highlighted in the box below.
in line with these criteria, the worldwide
core screening panel for donor cats (Table 1)
includes: feline leukaemia virus (FeLV), feline
immunodeficiency virus (FiV), Bartonella
species and feline haemoplasma.14,21,22 How -
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The risk of transmission of pathogens associ-
ated with xenotransfusion (transfusion of blood
obtained from a different animal species, usual-
ly dogs) is theoretically zero for FiV, FeLV and
feline haemoplasmas but may be relevant for
vector-borne infections, some of which are more
common in dogs than in cats.30 Xenotransfusion
should be restricted to exceptional circum-
stances (eg, emergencies in the event of lack of
compatible feline blood or oxygen carrier solu-
tion), as it is associated with delayed immune-
mediated haemolysis and a very short life span
of the transfused erythrocytes.31
Molecular techniques have significantly
increased the sensitivity and specificity of
diagnostic testing for the detection of feline
blood-borne agents, and their use has
increased the safety of blood products.
Healthy cats that test negative for FeLV p27
antigenaemia can still harbour provirus inte-
grated in their dNA, which means their blood
can transmit FeLV infection to transfused
cats.18 Blood bank donors should, therefore,
be tested for FeLV provirus using PCR. in life-
threatening emergency situations, transfu-
sions from donors can be screened using rapid
FeLV antigen tests, but owners should be
informed about the risk.
The screening of blood donors is also influ-
enced by costs. in human medicine, individual
blood units are usually tested for several
pathogens of major concern (eg, HiV, hepatitis
B, hepatitis C, Treponema pallidum); while, for
cost reasons, no testing is done for other trans-
missible blood-borne agents from healthy carri-
ers (Cytomegalovirus, West Nile virus, prions,
Leishmania, etc). The preliminary selection of
potential human donors is based on history and
a risk assessment related to history of travel, sex-
ual behaviour and certain medical procedures.
This is also true in the veterinary field; the
most useful, practical, rapid and inexpensive
measure to reduce transfusion risk is to check
the risk profile of donor cats prior to transfu-
sion, on the basis of a written questionnaire
completed by the guardian of the donor cat
(see box on page 591). This questionnaire can
be presented at the time of obtaining informed
consent for blood donation. The ideal low-risk
profile of a donor cat is described below. 
ever, the list of pathogens to be tested in donor
cats should be adapted to the local epidemio-
logical situation.23 other infectious agents 
that may be investigated in endemic areas are
listed in Table 2.
Two common feline infectious agents –
Toxoplasma gondii and feline coronavirus
(FCoV) – do not meet the ACViM criteria and
are not included in donor screening panels.14
The presence of antibodies against FCoV in
blood products may passively immunise
transfused cats. in the case of contact with the
virus in the weeks following transfusion, these
cats could be exposed to the risk of antibody-
dependent enhancement of macrophage infec-
tion.27,28 Although there have been no reports
of feline infectious peritonitis (FiP) following
blood transfusion in cats, FCoV-antibody 
negative blood bank donors are preferred.
Although Rickettsia felis and Rickettsia of the
other spotted fever group can infect cats, the
organisms have never been detected by molec-
ular methods in cat blood. At present, there is no
indication for testing cats for these pathogens.29
Pathogen Diagnostic tests
Feline leukaemia virus (FeLV) FeLV provirus PCR*†






Bartonella species Anti-Bartonella antibodies (IFAT) and/or
blood PCR
For more information on these pathogens, see Hosie et al,17 Lutz et al,18 Pennisi et al19
and Willi et al.20 PCR = polymerase chain reaction; IFAT = immunofluorescence
antibody test
*Tests for anti-FIV antibodies and FeLV DNA should be confirmed negative at least 
3 months after the last exposure
†In life-threatening emergency situations, donors can be screened using rapid FeLV
antigen tests, but owners should be informed about the higher risk




Cytauxzoon felis Blood PCR in endemic areas
Babesia species Blood PCR in endemic areas*
Leishmania infantum Blood PCR in endemic areas
Ehrlichia species Blood PCR in endemic areas*
Anaplasma phagocytophilum Anti-A phagocytophilum antibodies
(IFAT) and blood PCR in endemic areas
For more information on these pathogens, see Carli et al,24 Hartmann et al25
and Pennisi et al.26 PCR = polymerase chain reaction; IFAT = immunofluorescence
antibody test
*Probably rare and poorly characterised infection of cats in Europe
Pathogens to be considered for screening of candidate
blood donors based on local epidemiological information
Table 2
Ideal profile for a blood donor cat
< Adult (>3 years old, to reduce the risk of Bartonella bacteraemia)
< Living in the same single-cat household since a kitten (full history directly
available from the guardian)
< Regularly vaccinated and treated against fleas and ticks
< No history of travel or vector-borne diseases
< Heartworm prevention in endemic areas*
*Blood from cats infected with heartworm is, however, not infectious following
transfusion32
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Risk should be reassessed prior to each
transfusion. Risk assessment may eliminate
the need to repeat expensive and time-
consuming screening for blood-borne
pathogens in cats with low-risk profiles. The
required frequency of testing varies according
Figure 2 Topical application of autologous blood serum 
is used empirically as anticollagenolytic treatment in the
medical management of corneal lesions, but the procedure
requires strict asepsis. Courtesy of Maria Grazia Pennisi,
University of Messina, Messina, Italy




Gender: M / F Neutered:  Yes / No Age: ……………
Circle the correct answer
†When was your cat vaccinated last? …………………………………................
Please inform us of any observed change in the health status of your cat
in the next 15 days.
Date: ……………….. Signature: ………………………………….........
*Available to download as a Word document from the Supplementary 
material accompanying this article at jfms.com
If all answers are in the right-hand column, the cat has a low-risk profile
for transmission of infectious agents by blood.
How long have you owned this cat? Days Months Years
Is (or was) your cat free-roaming or has it (had)
any outdoor access?
Yes Don’t know No
Did you adopt your cat from a shelter? Yes Don’t know No
Was your cat a stray? Yes Don’t know No
Did you buy your cat from a pet shop or 
a cat breeder?
Yes Don’t know No
Is (or was) your cat in contact with other cats? Yes Don’t know No
Has your cat ever travelled to other countries? Yes Don’t know No
Has your cat had any health problem in the past? Yes Don’t know No
Has your cat had any drugs prescribed by a vet? Yes Don’t know No
Do you regularly use anti-flea products? No Don’t know Yes
Has your cat been vaccinated? No Don’t know Yes†
Is your cat eating less than usual? Yes Don’t know No
Have you recently seen any unusual behaviour? Yes Don’t know No
Has your cat vomited in the last few days? Yes Don’t know No
Has your cat had diarrhoea recently? Yes Don’t know No
Have you seen any change in urination? Yes Don’t know No
Have you seen any change in respiration? Yes Don’t know No
Have you noticed sneezing or coughing? Yes Don’t know No
Have you seen ocular or nasal discharge? Yes Don’t know No
to the pathogen (seasonal exposure or not)
and the individual recipient’s risk of acquir-
ing the infection. The ABCd does not recom-
mend the use of closed colony donors, which
are cats specifically bred for blood banks, as it
is preferable from a welfare perspective for
cats to live in a more natural environment.
if no feline blood is available from a blood
bank, veterinary practitioners should be able to
rely on an adequate number of pre-selected
potential donors evaluated as being low-risk
cats and negative for blood-borne pathogens of
interest. Free-roaming cats should never be
considered as potential donors. Shelter cats can
potentially be considered, dependent on their
history and the quality of management of the
shelter. Physical examination performed after
history taking should include an accurate
observation and combing of the coat to exclude
the presence of fleas and ticks. Cats with fleas
or ticks should not be considered as donors.14
occasional donors recruited in emergency
settings always reduce the level of safety of
blood transfusion. The need to find a compat-
ible blood donor rapidly may lead to the 
neglect of important requirements in terms of
donor health. Moreover, only in-house tests
can be used for assessing donors in emer-
gency cases, which implies they will be
screened only for retroviral infections follow-
ing a physical examination, complete blood
count (CBC), biochemical profile and urinaly-
sis. Where this approach is used, records of
the donor and recipient cats should be taken;
additionally an EdTA blood sample from the
donor should be kept (can be the same tube
and sample as taken for CBC), stored frozen
at –20°C, for possible further investigations.
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Other uses of blood products 
in practice
Topical application of blood serum is used
empirically as anticollagenolytic treatment in
the medical management of deep corneal
ulcers (Figure 2).33,34 The autologous prepara-
tion is cheap to prepare and easy to administer
in practice but strict aseptic conditions are
required, as described above for the collection
of blood. Sterile disposables (tube, pipette, 
eye dropper bottle) should be used to 
prevent bacterial contamination. The prepara-
tion should be stored at 4°C and used as soon
as possible (preferably within 48 h) because
the high administration frequency (up to 
once an hour) increases the risk of contamina-
tion of the contents of the eye drop bottle. in
the case of very young kittens, or when it is
impractical to bleed the patient, homologous
(feline) or even canine serum may be used. 
The administration of canine serum reduces
the risk of feline pathogen transmission to the
ocular mucosa and damaged corneal tissue.34
in the case of homologous serum, the donor
should be carefully selected, respecting the
same criteria as apply for blood trans fusion.
However, as there have been no 
controlled studies of the efficacy and safety 
of this therapy in cats, it should not be 
encouraged.
Autologous platelet-rich plasma is increas-
ingly used for treating orthopaedic conditions
in veterinary practice, including feline prac-
tice. The risk of bacterial contamination 
during preparation of the concentrate must be
minimised by strict hygiene.35
Conclusion
Blood transfusion can be a life-saving treatment
with a crucial impact on anaesthetic and surgi-
cal possibilities or intensive care, but it can
never be considered totally safe. The develop-
ment of infectious diseases in recipient cats is an
iatrogenic risk that must be minimised by the
highest standards of clinical veterinary practice.
despite increasing data on blood-borne infec-
tions and the availability of more sensitive diag-
nostic techniques, the risk of transmitting
pathogens using the blood of healthy infected
carriers cannot be eliminated entirely. The most
cost-effective action is to reduce this risk by the
pre-selection of low-risk donors.
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< Each step of the blood transfusion procedure should be performed under strict aseptic
conditions, even in emergencies.
< The longer the delay between blood collection and transfusion, the higher the risk of
contamination of the collected blood.
< Blood bags should be visually inspected before use and should be discarded if there is
any suspicion of change in colour or other visible abnormality.
< The core screening panel for donor cats worldwide includes FeLV, FIV, Bartonella species
and feline haemoplasma.
< Although the onset of FIP following blood transfusion in cats has not been reported,
FCoV antibody negative donors are preferred.
< The most practical, rapid and inexpensive preventive measure is to assess the 
risk profile of donor cats.
< Risk assessment may eliminate the need for repeating expensive and time-consuming
screening for blood-borne pathogens in cats with a low-risk profile.
< Free-roaming cats should never be considered as potential donors.
< Blood transfusion should be avoided in terminal patients.
KEY points
The risk of transmitting pathogens using the 
blood of healthy infected carriers must be
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